Skip to main content
Caplight Logo









Ceretas Limited

Ceretas Limited

Public

Ceretas Limited is now publicly traded

The data on this page reflects Ceretas Limited's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Grant

Sep 22, 2025

Total Funding Raised

$2.55M

Company Overview

Ceretas Limited is a healthtech company developing a non-invasive, safe, and portable therapeutic ultrasound platform to treat diseases of the brain, such as Alzheimer's disease.

AI Layer

Non-AI

Keywords

therapeutic ultrasoundneuromodulationblood-brain barrierneurodegenerative disease treatmentfocused ultrasoundmedical deviceAlzheimer's treatmentimage-guided therapybrain therapynon-invasive surgerymedtechdrug deliveryneuronavigationclinical-stage biotech

Ceretas Limited Comparables

Compare Ceretas Limited with similar companies based on industry and business-model similarity.

Ceretas Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Grey Matter Neurosciences
88%
Sound Wave Innovation Co., Ltd.
84%
Delsona Therapeutics
82%

Ceretas Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 22, 2025
SeedFeb 21, 2025

Key People

Founding team and executive leadership

Rachel de las Heras

Chief Executive Officer

Executive Team

Al Rey Lunar GAICD

Chief Financial Officer (part-time)

Executive Team

Ceretas Limited Investors

Notable investors and investment history

Ceretas Limited investors
InvestorRounds
Sequoia Asset ManagementSeed
CUREatorGrant
Caravel SecuritiesSeed

Recent news

Latest coverage and updates

  • is_developingSep 16, 2026

    Ceretas Pty Ltd is developing image-guided neuronavigation software on Jul 1st '25.

  • is_developingSep 16, 2026

    Ceretas Pty Ltd is developing portable, non-invasive therapeutic ultrasound platform on Jul 1st '25.

  • receives_financingSep 16, 2026

    Ceretas Pty Ltd will receive financing of $693K in non-dilutive funding on Sep 21st '26.

  • is_developingJul 24, 2026

    Ceretas Pty is developing portable, therapeutic focused-ultrasound device.

  • receives_financingJul 24, 2026

    Ceretas Pty Ltd received financing of $8M in IPO on Jul 23rd '26.

Ceretas Limited Filings

Explore SEC and related filing metadata, where available.

Ceretas Limited filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

Headquarters—
Employee Range6
Year Founded2024
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?